OSCR vs. EQH, AEG, BNT, RYAN, EG, GL, KNSL, BNRE, VOYA, and JXN
Should you be buying Oscar Health stock or one of its competitors? The main competitors of Oscar Health include Equitable (EQH), Aegon (AEG), Brookfield Wealth Solutions (BNT), Ryan Specialty (RYAN), Everest Group (EG), Globe Life (GL), Kinsale Capital Group (KNSL), Brookfield Reinsurance (BNRE), Voya Financial (VOYA), and Jackson Financial (JXN). These companies are all part of the "insurance" industry.
Oscar Health vs. Its Competitors
Oscar Health (NYSE:OSCR) and Equitable (NYSE:EQH) are both finance companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, media sentiment, earnings, institutional ownership, dividends, analyst recommendations, valuation and risk.
In the previous week, Equitable had 4 more articles in the media than Oscar Health. MarketBeat recorded 19 mentions for Equitable and 15 mentions for Oscar Health. Equitable's average media sentiment score of 1.42 beat Oscar Health's score of 0.90 indicating that Equitable is being referred to more favorably in the news media.
Equitable has higher revenue and earnings than Oscar Health. Oscar Health is trading at a lower price-to-earnings ratio than Equitable, indicating that it is currently the more affordable of the two stocks.
Oscar Health has a beta of 1.86, suggesting that its share price is 86% more volatile than the S&P 500. Comparatively, Equitable has a beta of 1.14, suggesting that its share price is 14% more volatile than the S&P 500.
Oscar Health presently has a consensus price target of $12.07, indicating a potential downside of 29.98%. Equitable has a consensus price target of $64.90, indicating a potential upside of 21.87%. Given Equitable's stronger consensus rating and higher possible upside, analysts plainly believe Equitable is more favorable than Oscar Health.
Equitable has a net margin of 3.51% compared to Oscar Health's net margin of -1.50%. Equitable's return on equity of 81.58% beat Oscar Health's return on equity.
75.7% of Oscar Health shares are owned by institutional investors. Comparatively, 92.7% of Equitable shares are owned by institutional investors. 24.4% of Oscar Health shares are owned by company insiders. Comparatively, 1.1% of Equitable shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Summary
Equitable beats Oscar Health on 14 of the 16 factors compared between the two stocks.
Get Oscar Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for OSCR and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding OSCR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Oscar Health Competitors List
Related Companies and Tools
This page (NYSE:OSCR) was last updated on 8/28/2025 by MarketBeat.com Staff
MarketBeat All Access